Human Pericytes for Ischemic Heart Repair

Author:

Chen Chien-Wen123,Okada Masaho23,Proto Jonathan D.234,Gao Xueqin23,Sekiya Naosumi235,Beckman Sarah A.234,Corselli Mirko6,Crisan Mihaela7,Saparov Arman8,Tobita Kimimasa91011,Péault Bruno612,Huard Johnny2311

Affiliation:

1. Department of Bioengineering,University of Pittsburgh, Pittsburgh, Pennsylvania, USA

2. Department of Orthopedic Surgery,University of Pittsburgh, Pittsburgh, Pennsylvania, USA

3. Stem Cell Research Center,University of Pittsburgh, Pittsburgh, Pennsylvania, USA

4. Department of Pathology,University of Pittsburgh, Pittsburgh, Pennsylvania, USA

5. Department of Surgery,University of Pittsburgh, Pittsburgh, Pennsylvania, USA

6. UCLA Orthopaedic Hospital, Department of Orthopaedic Surgery, and the Orthopaedic Hospital Research Center, University of California at Los Angeles, Los Angeles, California, USA

7. Erasmus MC Stem Cell Institute, Department of Cell Biology, Rotterdam, The Netherlands

8. Center for Energy Research, Nazarbayev University, Astana, Kazakhstan

9. Department of Pediatrics,University of Pittsburgh, Pittsburgh, Pennsylvania, USA

10. Department of Developmental Biology,University of Pittsburgh, Pittsburgh, Pennsylvania, USA

11. McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

12. Centre for Cardiovascular Science and Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom

Abstract

Abstract Human microvascular pericytes (CD146+/34−/45−/56−) contain multipotent precursors and repair/regenerate defective tissues, notably skeletal muscle. However, their ability to repair the ischemic heart remains unknown. We investigated the therapeutic potential of human pericytes, purified from skeletal muscle, for treating ischemic heart disease and mediating associated repair mechanisms in mice. Echocardiography revealed that pericyte transplantation attenuated left ventricular dilatation and significantly improved cardiac contractility, superior to CD56+ myogenic progenitor transplantation, in acutely infarcted mouse hearts. Pericyte treatment substantially reduced myocardial fibrosis and significantly diminished infiltration of host inflammatory cells at the infarct site. Hypoxic pericyte-conditioned medium suppressed murine fibroblast proliferation and inhibited macrophage proliferation in vitro. High expression by pericytes of immunoregulatory molecules, including interleukin-6, leukemia inhibitory factor, cyclooxygenase-2, and heme oxygenase-1, was sustained under hypoxia, except for monocyte chemotactic protein-1. Host angiogenesis was significantly increased. Pericytes supported microvascular structures in vivo and formed capillary-like networks with/without endothelial cells in three-dimensional cocultures. Under hypoxia, pericytes dramatically increased expression of vascular endothelial growth factor-A, platelet-derived growth factor-β, transforming growth factor-β1 and corresponding receptors while expression of basic fibroblast growth factor, hepatocyte growth factor, epidermal growth factor, and angiopoietin-1 was repressed. The capacity of pericytes to differentiate into and/or fuse with cardiac cells was revealed by green fluorescence protein labeling, although to a minor extent. In conclusion, intramyocardial transplantation of purified human pericytes promotes functional and structural recovery, attributable to multiple mechanisms involving paracrine effects and cellular interactions.

Funder

Commonwealth of Pennsylvania

National Institute of Health

Ministry of Education and Science of the Republic of Kazakhstan

American Heart Association predoctoral fellowship

California Institute for Regenerative Medicine

Publisher

Oxford University Press (OUP)

Subject

Cell Biology,Developmental Biology,Molecular Medicine

Reference50 articles.

1. Heart disease and stroke statistics–2011 update: A report from the American Heart Association;American Heart Association;Circulation,2011

2. Regeneration next: Toward heart stem cell therapeutics;Hansson;Cell Stem Cell,2009

3. Stem-cell therapy for cardiac disease;Segers;Nature,2008

4. Stem cells in the treatment of heart disease;Janssens;Ann Rev Med,2010

Cited by 214 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3